Development of immune radiotherapy with yttrium by targeting Frizzled homologue 10 (FZD10) in cervical cancer

Development of immune radiotherapy with yttrium by targeting Frizzled homologue 10 (FZD10) in cervical cancer

Objective: Radioimmunotherapy (RIT) is a combination of the therapeutic properties of radioisotopes and specific antibodies used to eliminate tumors. 90Y-OTSA101 was developed by labeling Frizzled homologue 10 (FZD10) antibody with Yttrium-90 (90Y). Because cervical cancer exhibits good radiosensiti...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuki Okuma, Yuji Ikeda, Osamu Kobayashi, Saki Kamata, Erina Matsuda, Takahiro Nakajima, Keisuke Saito, Naoko Tomita, Yoko Nakanishi, Yosuke Harada, Suyoun Chung, Jae-Hyun Park, Shinobu Masuda, Yusuke Nakamura, Kei Kawana
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Gynecologic Oncology Reports
Subjects:
Cervical Cancer
Radiotherapy
Immunotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S235257892500061X
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S235257892500061X

Similar Items